WO2002083063A3 - Method of improving systemic exposure of subcutaneously administered therapeutic proteins - Google Patents
Method of improving systemic exposure of subcutaneously administered therapeutic proteins Download PDFInfo
- Publication number
- WO2002083063A3 WO2002083063A3 PCT/US2001/051617 US0151617W WO02083063A3 WO 2002083063 A3 WO2002083063 A3 WO 2002083063A3 US 0151617 W US0151617 W US 0151617W WO 02083063 A3 WO02083063 A3 WO 02083063A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- therapeutic proteins
- systemic exposure
- subcutaneously administered
- administered therapeutic
- improving systemic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Abstract
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/415,738 US20040042999A1 (en) | 2001-11-01 | 2001-11-01 | Method of improving systemic exposure of subcutaneously administered therapeutic proteins |
JP2002580868A JP2004532843A (en) | 2000-11-03 | 2001-11-01 | Method for improving systemic exposure of therapeutic protein for subcutaneous administration |
EP01273890A EP1353622A4 (en) | 2000-11-03 | 2001-11-01 | Method of improving systemic exposure of subcutaneously administered therapeutic proteins |
AU2001297793A AU2001297793A1 (en) | 2000-11-03 | 2001-11-01 | Method of improving systemic exposure of subcutaneously administered therapeutic proteins |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US24561800P | 2000-11-03 | 2000-11-03 | |
US60/245,618 | 2000-11-03 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2002083063A2 WO2002083063A2 (en) | 2002-10-24 |
WO2002083063A3 true WO2002083063A3 (en) | 2003-08-28 |
Family
ID=22927410
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2001/051617 WO2002083063A2 (en) | 2000-11-03 | 2001-11-01 | Method of improving systemic exposure of subcutaneously administered therapeutic proteins |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1353622A4 (en) |
JP (1) | JP2004532843A (en) |
AU (1) | AU2001297793A1 (en) |
WO (1) | WO2002083063A2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008033499A2 (en) * | 2006-09-14 | 2008-03-20 | The Trustees Of The University Of Pennsylvania | Modulation of regulatory t cells by human il-18 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4847325A (en) * | 1988-01-20 | 1989-07-11 | Cetus Corporation | Conjugation of polymer to colony stimulating factor-1 |
EP0712913A1 (en) * | 1994-11-17 | 1996-05-22 | Canon Kabushiki Kaisha | Ink-jet color recording process and ink set therefor |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6600020B1 (en) * | 1997-08-07 | 2003-07-29 | Toray Industries, Inc. | Canine interleukin 18 polypeptide |
-
2001
- 2001-11-01 AU AU2001297793A patent/AU2001297793A1/en not_active Abandoned
- 2001-11-01 JP JP2002580868A patent/JP2004532843A/en active Pending
- 2001-11-01 WO PCT/US2001/051617 patent/WO2002083063A2/en active Application Filing
- 2001-11-01 EP EP01273890A patent/EP1353622A4/en not_active Withdrawn
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4847325A (en) * | 1988-01-20 | 1989-07-11 | Cetus Corporation | Conjugation of polymer to colony stimulating factor-1 |
EP0712913A1 (en) * | 1994-11-17 | 1996-05-22 | Canon Kabushiki Kaisha | Ink-jet color recording process and ink set therefor |
Non-Patent Citations (7)
Title |
---|
CANCER IMMUNOLOGY IMMUNOTHERAPY, vol. 43, no. 6, 1 January 1997 (1997-01-01), pages 361 - 367 * |
CYTOKINE, vol. 11, no. 8, August 1999 (1999-08-01), pages 593 - 599 * |
DATABASE MEDLINE [online] January 1997 (1997-01-01), MICALLEF: "IN VIVO ANTITUMOR EFFECTS OF MURINE INTERFERON-GAMMA-INDUCING FA TOR/INTERLEUKIN-18 IN MICE BEARING SYGENEIC METH A SARCOMA MALIGNANT ASCITES", XP002964696, Database accession no. 97220033 * |
DATABASE MEDLINE [online] TANAKA-KATAOKA: "IN VIVO ANTIVIRAL EFFECT OF INTERLEUKIN 18 IN A MOUSE OF VACCINIA VIRUS INFECTION", XP002964671, Database accession no. 99365045 * |
MASTROENI: "INTERLEUKIN 18 CONTRIBUTES TO HOST RESISTANCE AND GAMMA INTERFERON PRODUCTION IN MICE INFECTED WITH VIRULENT SALMONELLA TYPHIMURIUM", INFECTION AND IMMUNITY, vol. 67, no. 2, February 1999 (1999-02-01), pages 478 - 483, XP002964670 * |
OHKUSU: "POTENTIALITY OF INTERLEUKIN-18 AS A USEFUL REAGENT FOR TREATMENT AND PREVENTION OF LEISHMANIA MAJOR INFECTION", INFECTION AND IMMUNITY, vol. 68, no. 5, May 2000 (2000-05-01), pages 2449 - 2456, XP002964672 * |
See also references of EP1353622A4 * |
Also Published As
Publication number | Publication date |
---|---|
AU2001297793A1 (en) | 2002-10-28 |
EP1353622A2 (en) | 2003-10-22 |
EP1353622A4 (en) | 2005-06-22 |
WO2002083063A2 (en) | 2002-10-24 |
JP2004532843A (en) | 2004-10-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU6271401A (en) | Drug administering system and administering method | |
AU2001279064A1 (en) | Therapeutic azo-compounds for drug delivery | |
HK1047575A1 (en) | Indanyl-substituted benzole carbonamide, method for the production of the same, use thereof as a medicament and pharmaceutical preparations containingthe same. | |
AU2001276737A1 (en) | Protein injection preparations | |
AU2001256148A1 (en) | Subcutaneous administration of coagulation factor vii | |
AU5945296A (en) | Medicament for nasal administration | |
AUPQ867900A0 (en) | Medical injector system | |
WO1999007401A3 (en) | The use of erythropoietin and iron preparations for producing pharmaceutical combination preparations for treating rheumatic diseases | |
AU2002213698A1 (en) | Needleless syringe for the subcutaneous delivery of therapeutic agents | |
AU2001296800A1 (en) | Systemic delivery of compounds through non-invasive bladder administration | |
AU2001284444A1 (en) | Preparations for oral administration | |
AU777185C (en) | Pharmaceutical form of administration for peptides, methods for its production and use | |
AU2000265525A1 (en) | Medicament for treating intestinal diseases | |
HK1022432A1 (en) | Administration of histamine for therapeutic purposes. | |
AU5289899A (en) | Transmucosal therapeutic system for administering sildenafil | |
AU2001243515A1 (en) | Combination drug therapy | |
WO2001036656A3 (en) | A complex between hyaluronic acid and a biomolecule and its use | |
AU2002332836A1 (en) | Stabilizing catheter for protein drug delivery | |
WO2002083063A3 (en) | Method of improving systemic exposure of subcutaneously administered therapeutic proteins | |
IT1293583B1 (en) | Treating demential syndromes comprising administration of gammahydroxybutyric acid | |
AU2002222557A1 (en) | Interferon therapeutic effect-potentiating agents | |
AU3393600A (en) | Method for safely and effectively administering a drug by inhalation | |
ZA200210361B (en) | Method of administering bishosphonates. | |
AU2002210439A1 (en) | Method for producing peptide salts, their use, and pharmaceutical preparations containing these peptide salts | |
MXPA03006157A (en) | Hormone replacement therapy method and its administration form. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 10415738 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2001273890 Country of ref document: EP Ref document number: 2002580868 Country of ref document: JP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWP | Wipo information: published in national office |
Ref document number: 2001273890 Country of ref document: EP |